Our work doesn't matter when we become silent about things that really matter
- The cost of new anti-cancer drugs increased more than fivefold from 2006 to 2015.
- Anticancer medications account for the lion’s share of global drug spending, and the average price per month of these drugs is known to have more than doubled in recent years
- Cost is not connected with benefit, and cost is going up quickly, and benefit is highly variable.
- ASCO and other groups are supporting efforts to make cancer drug costs relate to their effectiveness.